Volver a la listaCompany

Startups bio enfrentan desafío del mercado de EE.UU. — desde KIC Washington

2022-02-16

KIC Washington D.C. Accelerator Collaborates with MassChallenge
Five empresas to participate in Bio iCORE Program through 2023

https://www.hellodd.com/news/articleView.html?idxno=95343

The Bio iCORE programa includes five empresas seleccionada as final global startup teams — NeuroEars, STEMDEN, RudaCure, and two others — and will run through March 2023.

MassChallenge prioritizes public benefit and the advancement of human welfare alongside profitability, and does not require equity or management rights from startups. This programa is a colaboración between KIC DC and MassChallenge, providing prometedor Korean bio-tech empresas with opportunities to meet global entrepreneurs, inversores, and tecnología experts. It aims to apoyo the successful expansión global of outstanding Korean bio startups through education, training, and mentoring.
Volver a la lista